BioSpace News Archive

Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will present a corporate update at the China Healthcare Investment Conference at the Ritz-Carlton Shanghai Pudong Hotel in Shanghai, China on March 26 - 28.

Poster supports rationale for recently initiated Phase 1/2 doublet clinical trial studying novel combination of Actimab-A and venetoclax and planned Phase 1/2 triplet combination trial of Actimab-A and venetoclax with a hypomethylating agent

Company’s First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units to be Highlighted at 39th Annual ISICEM Conference

Data Will Also Be Presented at the Upcoming 23rd Israeli Congress for Emergency Medicine

The National Association of Women Business Owners (NAWBO) is supporting bipartisan efforts in the U.S. Senate aimed at extending the current moratorium on the Health Insurance Tax (HIT) or eliminating it altogether

Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in the Midwest that the Henry Schein Disaster Relief Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the recent flooding.

Announced the addition of two experts in drug discovery and development to its leadership team.

Yongchang Qiu, Ph.D., Named Vice President, Preclinical Development; Ryan Tyler, Ph.D., Named Senior Director, Preclinical Research; Niels Svenstrup, Ph.D., Promoted to Senior Vice President, Development

According to the newly-released ePA National Adoption Scorecard and the Real-Time Benefit Check National Adoption Scorecard, most EHRs, health systems, payers and pharmacies have committed to electronic prior authorization (ePA) and real-time benefit check solutions; however, attaining patient-benefit from these platforms relies on broader provider utilization.

America’s leading science-focused multi-state cannabis company